Abstract 2618: Staged analysis of standard of care tumor molecular testing among patients with metastatic colorectal cancer in the community health system setting
Chenan Zhang, Thomas D. Brown, Michael A. Thompson(The University of Melbourne), Yanina Natanzon, Joseph R. Burkhart, Ronda Broome, Mahder Teka, Francesca F. Coutinho, James L. Weese(Penn Presbyterian Medical Center), Louise E. Widmer, Anna B. Berry, Douglas J. Reding(Ascension), Mary Tran, Jennifer Godden(Aurora Health Care), Antony Ruggeri(Aurora Health Care)
Cited by 0
Related Papers
Mortality Results from a Randomized Prostate-Cancer Screening Trial
|New England Journal of Medicine|2009|2.9k
Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up
|JNCI Journal of the National Cancer Institute|2012|1.1k
Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial
|Controlled Clinical Trials|2000|1k
Colorectal-Cancer Incidence and Mortality with Screening Flexible Sigmoidoscopy
|New England Journal of Medicine|2012|1k
Screening by Chest Radiograph and Lung Cancer Mortality
|JAMA|2011|659